DAFNA Capital Management LLC CYTK Holdings History
DAFNA Capital Management LLC's Cytokinetics Inc Holding Summary
As of 2025-03-31, DAFNA Capital Management LLC held 398,100.00 shares of Cytokinetics Inc(CYTK), totaling $16.00 Mil. This investment constitutes 4.6% of their stock portfolio, and DAFNA Capital Management LLC now holds 0.33% of the outstanding Cytokinetics Inc(CYTK) stock.
The initial trade took place in 2015Q4. And since then DAFNA Capital Management LLC has made 10 purchases of CYTK, at an average price of $21.79, for a total of 1.03 Mil shares. In addition, there have been 7 sales at an average price of $19.03 for 633,787.00 shares. Based on historical transaction data and CYTK's current price of $37.70, DAFNA Capital Management LLC's estimated gain on his CYTK holdings is $4.59 Mil, reflecting a 20.42% gain to date.
DAFNA Capital Management LLC CYTK ($37.70) Holding Chart
DAFNA Capital Management LLC CYTK ($37.70) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
